|
|
Volumn 2, Issue 6, 2000, Pages 440-445
|
|
Clinical pharmacology of inflammatory bowel disease therapies.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
BIOLOGICAL MARKER;
CORTICOSTEROID;
GLUCOCORTICOID RECEPTOR;
IMMUNOSUPPRESSIVE AGENT;
MESALAZINE;
METHOTREXATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
CHEMISTRY;
CROHN DISEASE;
DRUG RESISTANCE;
ENTERITIS;
HUMAN;
INTESTINE MUCOSA;
METABOLISM;
PHARMACOGENETICS;
REVIEW;
ULCERATIVE COLITIS;
ADRENAL CORTEX HORMONES;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
AZATHIOPRINE;
BIOLOGICAL MARKERS;
COLITIS, ULCERATIVE;
CROHN DISEASE;
DRUG RESISTANCE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFLAMMATORY BOWEL DISEASES;
INTESTINAL MUCOSA;
MESALAMINE;
METHOTREXATE;
PHARMACOGENETICS;
RECEPTORS, GLUCOCORTICOID;
|
|
EID: 0001663775
PISSN: 15228037
EISSN: None
Source Type: Journal
DOI: 10.1007/s11894-000-0005-0 Document Type: Review |
|
Times cited : (27)
|
|
References (48)
|
